CION Ameerpet
Immunotherapy Side Effects · Hormone & Endocrine Reactions
Endocrine Effects in Young Patients — Fertility and Puberty
Immunotherapy can occasionally affect the thyroid, pituitary, or gonadal hormones that drive fertility and puberty in young patients — but not in most patients, and long-term data on exactly who is affected, and how much, is still limited. Being honest about that uncertainty, rather than offering false reassurance either way, is the starting point for this page. NCCN and ASCO guidance on immune-related adverse events flags endocrine irAEs for active monitoring, and specifically notes that reproductive and pubertal follow-up data in younger patients remains an evidence gap.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026
- Vague symptoms get dismissed — irregular periods, low energy, or stalled puberty signs are easy to write off as unrelated.
- Know the crisis signs — a rare pituitary/adrenal complication can turn into a genuine emergency even in young, fit patients.
- Long-term data is limited — we say so plainly, instead of promising an outcome the evidence doesn't support.
- Preservation can be discussed early — fertility options are best raised with the team before treatment starts, when timing allows.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Emergency first
What Are the Emergency Warning Signs in a Young Patient on Immunotherapy?
Endocrine reactions to immunotherapy occasionally involve the pituitary or adrenal glands, and in rare cases this can trigger an adrenal crisis — a life-threatening emergency that can affect young, otherwise fit patients too. Severe vomiting, collapse, confusion, or sudden severe abdominal pain need emergency care immediately, not a wait-and-see approach.
Go to the ER now, or call an ambulance, if you or your young patient have any of these:
- Severe vomiting or diarrhoea, or being unable to keep fluids down
- Collapse, fainting, or severe dizziness
- Confusion or extreme drowsiness
- Sudden severe abdominal, back, or leg pain
- A known diagnosis of adrenal insufficiency plus fever, injury, or another physical stress
For ongoing but non-emergency symptoms — irregular periods, low energy, stalled puberty signs, or low libido — call the CION helpline the same day:
Call the CION Helpline Now: 1800 202 8726
The honest answer
Does Immunotherapy Affect Fertility in Young Patients?
Immunotherapy can affect fertility in young patients if it triggers an immune reaction in the thyroid, pituitary, or gonadal hormone pathways, but this does not happen to most patients, and current evidence is too limited to predict who it will affect or by how much. Irregular periods, delayed puberty signs, or reduced libido during or after treatment should be reported to the care team rather than assumed to pass on their own. Fertility can also be affected by chemotherapy or radiation given alongside immunotherapy, so any change is assessed by the full oncology team, not attributed to immunotherapy alone.
What the evidence actually shows
Is the Data on Long-Term Fertility and Puberty Effects Really Limited?
Yes — and saying so plainly is more useful to a young patient and their family than a reassuring guess. Most immunotherapy trials were not designed to track fertility, puberty, or reproductive outcomes years after treatment, and follow-up periods are frequently too short to answer that question with confidence. NCCN and ASCO guidance on immune-related adverse events acknowledges this gap directly and recommends individualised counselling rather than a standard answer applied to everyone. That means it is entirely reasonable to ask your care team "what do we actually know, and what don't we know yet" and expect a direct answer, not a general reassurance.
Timing matters
When Do Endocrine Effects on Fertility or Puberty Typically Appear?
Endocrine irAEs affecting fertility or puberty don't follow one fixed timeline — thyroid changes are usually the earliest to show up on blood tests, while pituitary and gonadal effects can appear later and are harder to predict. This is one more reason ongoing hormone monitoring matters more than watching for obvious symptoms alone.
| Stage | What's typically happening |
|---|---|
| Typically starts | Thyroid effects can appear within the first few months; pituitary and gonadal effects can appear later, sometimes only after many months or after treatment has ended. |
| Early phase | Subtle changes — irregular periods, low libido, stalled pubertal signs, or mild fatigue that's easy to mistake for ordinary treatment tiredness. |
| If unreported | Can progress to more pronounced hormone deficiency, and where the pituitary/adrenal axis is involved, occasionally to an adrenal crisis triggered by illness or physical stress. |
There is no home-management step for ongoing hormone symptoms in a young patient on immunotherapy — the correct response is always to get hormone levels checked, or go to the ER for the emergency signs above.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Don't Wait Out Hormone or Puberty Changes on Immunotherapy
Our tumour board includes the same specialists managing your immunotherapy — reach them directly.
A framework, not a rule
Should Fertility Preservation Be Discussed Before Starting Immunotherapy?
There is no single right answer here — it depends on the cancer, the timeline available, the patient's age and pubertal stage, and what the family wants. What matters is that the conversation happens early enough to keep options open, rather than being raised after treatment has already started.
- 1
Raise it with the oncology team as early as possible
Ideally before immunotherapy — or any combined chemotherapy/radiation — begins, since some preservation options close once treatment starts.
- 2
Ask for a referral to a fertility specialist
Fertility preservation is arranged through a specialist working alongside the cancer team, not decided within oncology alone.
- 3
Understand which options apply
What's realistic depends heavily on age and pubertal stage — options for a post-pubertal adult differ from those for a pre-pubertal child.
- 4
Weigh preservation time against cancer urgency
Some cancers cannot wait for a preservation cycle to complete — this trade-off is discussed openly, not assumed.
- 5
Document the decision either way
Whether preservation is pursued or not, having it recorded and discussed avoids the question resurfacing with regret later.
Ongoing care
How Is Puberty Monitored During Immunotherapy?
For adolescent patients, the paediatric or adolescent oncology team tracks growth and pubertal development alongside routine hormone blood tests, rather than relying on how a young patient looks or feels. If puberty appears to be stalling, or growth has slowed compared with what's expected for age, this is checked with thyroid, pituitary, and gonadal hormone panels rather than assumed to be a normal part of being unwell with cancer.
A clinician-directed decision
Will Hormone Replacement Be Needed for Life?
For some young patients whose thyroid, pituitary, or gonadal hormone levels are affected by immunotherapy, ongoing hormone replacement is needed, and in a smaller number of cases this continues long-term. Whether that applies to a specific patient, and for how long, is decided by the endocrinology and oncology team together based on repeat hormone tests over time — it is never something a patient or family should decide, start, or stop independently.
Care during treatment
Immune Reactions Are Manageable When Caught Early
Young patients and families who ask early are supported by the same multidisciplinary team throughout treatment.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Fertility and Puberty Effects in Young Patients: Your Questions Answered
Does immunotherapy affect fertility in young patients?
Immunotherapy can affect fertility in young patients if it triggers an immune reaction in the thyroid, pituitary, or gonadal (ovary or testis) hormone pathways, but this does not happen to most patients and current evidence is too limited to predict who it will affect or to what degree. Some young patients report irregular periods, delayed puberty signs, or reduced libido during or after treatment, which should be reported to the care team rather than assumed. Fertility can also be affected by other cancer treatments given alongside immunotherapy, such as chemotherapy or radiation, so any change should be assessed by the full oncology team, not attributed to immunotherapy alone.
Is the long-term data on fertility and hormone effects in young patients limited?
Yes, and being upfront about that is important. Most immunotherapy trials were not designed to track long-term fertility, puberty, or reproductive outcomes in young patients specifically, and follow-up periods are often too short to know what happens years later. Guideline bodies such as NCCN and ASCO acknowledge this gap and recommend individualised counselling rather than blanket reassurance or blanket warnings. This means a young patient and their family should expect honest uncertainty from their care team on this specific question, and should ask directly rather than assume either a good or bad outcome.
Should fertility preservation be discussed before starting immunotherapy?
Fertility preservation is worth raising with the oncology team before treatment starts whenever timing allows, especially if immunotherapy is being combined with chemotherapy or radiation, which carry clearer fertility risks of their own. Options such as egg or sperm freezing are typically arranged through a referral to a fertility specialist working alongside the cancer team, and the decision depends on cancer urgency, age, pubertal stage, and personal or family wishes. This is a conversation to have as early as possible — once treatment has begun, some preservation options are no longer practical.
Can immunotherapy delay or affect puberty in teenagers?
In a small proportion of young patients, an immune reaction affecting the pituitary or thyroid gland can slow or alter the hormones that drive puberty, causing delayed or stalled pubertal development. This is uncommon and is monitored for during routine hormone blood tests rather than assumed from appearance alone. If a teenager on immunotherapy is not progressing through puberty as expected, or growth appears to have slowed, this should be raised with the paediatric or adolescent oncology team so hormone levels can be checked.
What are the emergency warning signs of an endocrine crisis during immunotherapy?
Severe vomiting or diarrhoea, collapse or fainting, confusion, sudden severe abdominal pain, or extreme weakness can signal an adrenal crisis, a rare but life-threatening endocrine emergency that can occur even in young, otherwise healthy patients on immunotherapy. These signs need emergency care immediately — call an ambulance or go to the nearest emergency room rather than waiting to see if they pass. Vague symptoms like ongoing tiredness or nausea without these red flags should still be reported to the care team the same day, but are not by themselves an emergency.
Will hormone replacement be needed for life after immunotherapy?
For some young patients whose thyroid, pituitary, or gonadal hormone levels are affected by immunotherapy, ongoing hormone replacement is needed, and in a smaller number of cases this continues long-term. Whether that applies to a specific patient, and for how long, is decided by the endocrinology and oncology team together based on repeat hormone tests over time — it is never something to decide, start, or stop independently. Families should expect this to be revisited periodically rather than settled once and left unchecked.